Adalimumab
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Adalimumab |
| DrugBank ID | DB00051 |
| KG Predictions | 180 |
| DL Predictions (≥0.7) | 130 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 180 knowledge graph predictions and 130 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| inflammatory bowel disease | KG |
| dyshidrosis | KG |
| rheumatoid arthritis | KG |
| spondyloarthropathy, susceptibility to | KG |
| hidradenitis suppurativa | KG |
| Crohn disease | KG |
| Crohn’s colitis | KG |
| psoriatic arthritis | KG |
| ankylosing spondylitis | KG |
| hidradenitis | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB00051
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.